-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RHzvZjpw1ug0F3VRkKAmacXuY/IPc37TQw7wXwbDbw9srC67hpoLAFtMWqhGQrdn Ka8LQr3mZ9AWCd2OAiIIXw== 0000922423-96-000384.txt : 19960807 0000922423-96-000384.hdr.sgml : 19960807 ACCESSION NUMBER: 0000922423-96-000384 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19960806 SROS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: QLT PHOTO THERAPEUTICS INC CENTRAL INDEX KEY: 0000827809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-43381 FILM NUMBER: 96604093 BUSINESS ADDRESS: STREET 1: 520 W 6TH AVE STREET 2: STE 200 CITY: VANCOUVER BC CANADA STATE: A1 BUSINESS PHONE: 6048727881 FORMER COMPANY: FORMER CONFORMED NAME: QUADRA LOGIC TECHNOLOGIES INC DATE OF NAME CHANGE: 19941201 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: T A L INVESTMENT COUNSEL LTD CENTRAL INDEX KEY: 0001020338 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1000 DE LA GAUCHETIERE WEST SUITE 3100 CITY: MONTREAL STATE: A8 ZIP: 0000000000 BUSINESS PHONE: 2127159245 MAIL ADDRESS: STREET 1: 1000 DE LA GAUCHETIERE WEST STREET 2: SUITE 3100 CITY: MONTREAL QUEBEC CAND STATE: A8 ZIP: 0000000000 SC 13G 1 INFORMATION STATEMENT SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 __________ SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 QLT Phototherapeutic Inc. ----------------------------------------- (Name of Issuer) Common Stock ----------------------------------------- (Title of Class of Securities) 74692710 -------------- (CUSIP Number) __________ Check the following box if a fee is being paid with this statement |X|. Page 1 of 7 Pages SCHEDULE 13G CUSIP No. 74692710 Page 2 of 7 Pages - -------------------------------------------------------------------------------- 1) NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON T.A.L. Investment Counsel Ltd. - -------------------------------------------------------------------------------- 2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) |_| (b) |_| - -------------------------------------------------------------------------------- 3) SEC USE ONLY - -------------------------------------------------------------------------------- 4) CITIZENSHIP OR PLACE OF ORGANIZATION Canada - -------------------------------------------------------------------------------- 5) SOLE VOTING POWER 1,179,975 shares of Common Stock NUMBER ------------------------------------------------- OF 6) SHARED VOTING POWER SHARES Not applicable BENEFICIALLY ------------------------------------------------- OWNED BY 7) SOLE DISPOSITIVE POWER EACH 1,373,600 shares of Common Stock REPORTING ------------------------------------------------- PERSON 8) SHARED DISPOSITIVE POWER WITH Not applicable - -------------------------------------------------------------------------------- 9) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,375,850 shares of Common Stock - -------------------------------------------------------------------------------- 10) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| - -------------------------------------------------------------------------------- 11) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.78% - -------------------------------------------------------------------------------- 12) TYPE OF REPORTING PERSON IA - -------------------------------------------------------------------------------- -2- Schedule 13G ITEM 1(A). NAME OF ISSUER: QLT Phototherapeutic Inc. ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: QLT Place, 520 West 6th Avenue, Vancouver, British Columbia V5Z 4H5 ITEM 2(A). NAME OF PERSON FILING: T.A.L. Investment Counsel Ltd. ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The principal business office is 1000 de la Gauchetiere West, Suite 3100, Montreal, Quebec, Canada H3B 4W5 ITEM 2(C). CITIZENSHIP: Canada ITEM 2(D). TITLE OF CLASS OF SECURITIES: Common Stock ITEM 2(e). CUSIP NUMBER: 74692710 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b), CHECK WHETHER THE PERSON FILING IS A: (e) |X| Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 ITEM 4. OWNERSHIP. (a) Amount beneficially owned: 1,375,850 shares of Common Stock (b) percent of class: 6.78% (c) Number of shares as to which such person has: -3- (i) Sole power to vote or to direct the vote: 1,179,975 shares of Common Stock (ii) Shared power to vote or to direct the vote: Not applicable (iii) Sole power to dispose or to direct the disposition of: 1,373,600 shares of Common Stock (iv) Shared power to dispose or to direct the disposition of : Not applicable ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS. Not applicable ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the common stock of QLT Phototherapeutic Inc. No one person's interest in the common stock of QLT Phototherapeutic Inc. is more than five percent of the total outstanding common stock. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY. Not applicable ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP. Not applicable ITEM 9. NOTICE OF DISSOLUTION OF GROUP. Not applicable ITEM 10. CERTIFICATION. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. -4- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Schedule 13G in connection with T.A.L. Investment Counsel Ltd.'s beneficial ownership of the common stock of QLT Phototherapeutic Inc. at December 31, 1995 is true, complete and correct. Date: August 5, 1996 T.A.L. INVESTMENT COUNSEL LTD. /s/ Assunta Di Lorenzo ---------------------- By: Assunta Di Lorenzo Legal Counsel and Corporate Secretary -5- -----END PRIVACY-ENHANCED MESSAGE-----